Your browser is no longer supported. Please, upgrade your browser.
Settings
EGRX Eagle Pharmaceuticals, Inc. daily Stock Chart
EGRX [NASD]
Eagle Pharmaceuticals, Inc.
Index- P/E15.99 EPS (ttm)5.00 Insider Own0.20% Shs Outstand15.23M Perf Week-1.71%
Market Cap1.22B Forward P/E18.58 EPS next Y4.30 Insider Trans-96.27% Shs Float13.83M Perf Month5.83%
Income81.50M PEG1.07 EPS next Q1.42 Inst Own86.10% Short Float25.51% Perf Quarter5.65%
Sales189.50M P/S6.42 EPS this Y-20.20% Inst Trans-4.44% Short Ratio11.26 Perf Half Y19.67%
Book/sh9.89 P/B8.08 EPS next Y13.61% ROA51.00% Target Price85.00 Perf Year106.51%
Cash/sh- P/C- EPS next 5Y15.00% ROE71.30% 52W Range33.02 - 87.78 Perf YTD0.68%
Dividend- P/FCF32.53 EPS past 5Y58.40% ROI53.80% 52W High-8.99% Beta-
Dividend %- Quick Ratio2.60 Sales past 5Y81.90% Gross Margin70.80% 52W Low141.91% ATR3.54
Employees77 Current Ratio2.70 Sales Q/Q345.60% Oper. Margin28.10% RSI (14)56.25 Volatility5.31% 4.86%
OptionableYes Debt/Eq0.00 EPS Q/Q4600.70% Profit Margin43.00% Rel Volume0.96 Prev Close81.83
ShortableYes LT Debt/Eq0.00 EarningsMar 01 BMO Payout0.00% Avg Volume313.47K Price79.88
Recom2.30 SMA201.39% SMA509.15% SMA20023.31% Volume299,538 Change-2.38%
Jan-09-17Downgrade Mizuho Neutral → Underperform $78 → $64
Nov-16-16Downgrade Mizuho Buy → Neutral $78
Nov-03-16Upgrade Mizuho Neutral → Buy $62 → $78
Nov-03-16Reiterated RBC Capital Mkts Outperform $80 → $93
Oct-26-16Reiterated Mizuho Buy $65 → $62
Aug-16-16Reiterated Mizuho Neutral $47 → $65
Jun-20-16Downgrade Mizuho Buy → Neutral $66 → $47
May-10-16Reiterated RBC Capital Mkts Outperform $94 → $78
Mar-18-16Reiterated Mizuho Buy $81 → $71
Feb-26-16Reiterated Mizuho Buy $112 → $81
Dec-09-15Initiated Mizuho Buy $112
Jul-29-15Reiterated Piper Jaffray Overweight $94 → $119
Jul-06-15Reiterated Piper Jaffray Overweight $75 → $94
Jun-16-15Reiterated Cantor Fitzgerald Buy $65 → $95
Apr-20-15Reiterated Piper Jaffray Overweight $55 → $75
Mar-10-14Initiated William Blair Outperform
Mar-26-17 06:43AM  3 Top Biotech Stocks to Buy in 2017 at Motley Fool
Mar-24-17 01:23PM  Director of Eagle Pharmaceuticals Buys Shares
Mar-21-17 01:04PM  EAGLE PHARMACEUTICALS, INC. Financials -7.11%
10:24AM  Eagle Pharma Cancer Drug Secures New Patents at Investopedia
08:00AM  Eagle Pharmaceuticals Announces Three New Patents Issued for Bendeka Business Wire
Mar-16-17 07:11AM  EAGLE PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure,
07:00AM  Eagle Pharmaceuticals Appoints Richard A. Edlin to Board of Directors Business Wire
Mar-15-17 05:25PM  EAGLE PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report
Mar-06-17 10:10AM  New Strong Sell Stocks for March 6th
Mar-03-17 11:59AM  Eagle Pharmaceuticals, Inc. :EGRX-US: Earnings Analysis: Q4, 2016 By the Numbers : March 3, 2017
Mar-02-17 01:37PM  Eagle Pharmaceuticals, Inc. :EGRX-US: Earnings Analysis: 2016 By the Numbers : March 2, 2017
Mar-01-17 04:36PM  Edited Transcript of EGRX earnings conference call or presentation 1-Mar-17 1:30pm GMT
07:07AM  Q4 2016 Eagle Pharmaceuticals Inc Earnings Release - Before Market Open
07:04AM  Eagle Pharmaceuticals posts 4Q profit
06:57AM  EAGLE PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a
06:50AM  Eagle Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2016 Results Business Wire
Feb-28-17 09:01AM  Eagle Pharmaceuticals Pemetrexed NDA Accepted for Filing by the FDA Business Wire
08:26AM  MedTech Stocks' Q4 Earnings on Mar 1: ICUI, GKOS & EGRX
07:55AM  Eagle Pharmaceuticals Announces 11th Patent Issued for Bendeka Business Wire
Feb-21-17 09:34AM  Eagle Pharmaceuticals Announces New Patents Issued for Bendeka Business Wire
Feb-16-17 07:00AM  Eagle Pharmaceuticals, Inc. to Discuss Fourth Quarter and Full Year 2016 Financial Results on March 1, 2017 Business Wire
Feb-13-17 04:30PM  Eagle Pharmaceuticals to Present at 2017 RBC Capital Markets Global Healthcare Conference Business Wire
Feb-01-17 05:30PM  EAGLE PHARMACEUTICALS, INC. Files SEC form 8-K/A, Financial Statements and Exhibits
Jan-31-17 04:45PM  EAGLE PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Fina
Jan-25-17 08:37AM  Falling Earnings Estimates Signal Weakness Ahead for Eagle Pharmaceuticals (EGRX)
Jan-24-17 09:21AM  Eagle Pharmaceuticals Wraps Up Ryanodex NDA Submission
Jan-23-17 06:50AM  Eagle Pharmaceuticals Completes NDA Submission for Ryanodex for Exertional Heat Stroke to FDA Business Wire
Jan-16-17 07:44AM  New Strong Sell Stocks for January 16th
Jan-11-17 06:09AM  EAGLE PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits -5.31%
Jan-10-17 04:48PM  EAGLE PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
10:41AM  Eagle Pharmaceuticals, Inc. Value Analysis (NASDAQ:EGRX) : January 10, 2017
Jan-09-17 08:05AM  Eagle Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : EGRX-US : January 9, 2017 -9.41%
06:12AM  Eagle Pharma downgraded by Mizuho
Jan-06-17 04:39PM  EAGLE PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers -8.55%
Jan-04-17 06:50AM  Eagle Pharmaceuticals to Present at J.P. Morgan 35th Annual Healthcare Conference Business Wire +6.00%
Jan-03-17 06:50AM  Eagle Pharmaceuticals Pemetrexed NDA Submitted for Review Business Wire
Dec-28-16 08:02AM  Myriad Genetics' Unit Releases Favorable Data on Vectra DA
Dec-19-16 05:01PM  EAGLE PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure,
08:00AM  Eagle Pharmaceuticals Announces David Pernock as President and Chief Commercial Officer Business Wire
Dec-14-16 06:03AM  EAGLE PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Dec-13-16 06:50AM  Eagle Pharmaceuticals Reports Positive Results from Pivotal Animal Study Supporting the Efficacy of RYANODEX for Exertional Heat Stroke Business Wire
Dec-12-16 08:58AM  Why Eagle Pharmaceuticals (EGRX) Could Shock the Market Soon
Dec-05-16 02:04AM  Hedge Funds Arent Crazy About Photronics, Inc. (PLAB) Anymore at Insider Monkey
Nov-28-16 11:28AM  Increased Earnings Estimates Seen for Eagle Pharmaceuticals (EGRX): Can It Move Higher?
Nov-22-16 09:30AM  The Zacks Analyst Blog Highlights: Best Buy, Edgewell Personal Care and Eagle Pharma
Nov-21-16 09:25AM  Black Friday Approaches: Global Week Ahead
07:00AM  Eagle Pharmaceuticals to Present at Piper Jaffray 28th Annual Healthcare Conference Business Wire
Nov-16-16 05:04PM  EAGLE PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equi -7.58%
Nov-14-16 04:32PM  Eagle Keeps Outperform Rating On $400 Million Breast-Cancer Drug
08:15AM  Blog Coverage Eagle Pharma on a Biosimilar Development Initiative Sets to Acquire Arsia Therapeutics Accesswire
07:57AM  EAGLE PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equi
Nov-11-16 03:39PM  Eagle Pharmaceuticals, Inc.: Leads amongst peers with strong fundamentals -5.60%
09:41AM  Is Eagle Pharmaceuticals (EGRX) Stock a Solid Choice Right Now?
07:00AM  Eagle Pharmaceuticals Signs Definitive Agreement to Acquire Arsia Therapeutics Marking Entry into Biosimilar Market Business Wire
06:55AM  Eagle Pharmaceuticals Initiates Rolling Submission of NDA for Ryanodex in Exertional Heat Stroke Business Wire
Nov-10-16 10:10AM  Company News for November 10, 2016
Nov-09-16 04:30PM  Eagle Pharmaceuticals to Present at Jefferies 2016 London Healthcare Conference Business Wire +11.79%
10:26AM  Edited Transcript of EGRX earnings conference call or presentation 9-Nov-16 1:30pm GMT
07:07AM  Q3 2016 Eagle Pharmaceuticals Inc Earnings Release - Before Market Open
06:54AM  Eagle Pharmaceuticals posts 3Q profit
06:50AM  Eagle Pharmaceuticals, Inc. Reports Third Quarter 2016 Results Business Wire
Nov-08-16 08:08AM  Medical Product Q3 Earnings on Nov 9: ICUI, EGRX & More
Nov-07-16 06:03PM  First Eagle Investment Management's Top 5 Stock Buys of 3rd Quarter
Nov-04-16 09:22AM  Will Eagle Pharmaceuticals (EGRX) Continue to Surge Higher? +5.43%
Nov-03-16 04:49PM  EAGLE PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
04:13PM  Eagle Pharma, Teva Pharma Diverge On 'Surprise' Leukemia Drug Win
08:03AM  Eagle Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : EGRX-US : November 3, 2016
Nov-02-16 01:35PM  Stocks Sink But Medical Sector Climbs; Google Parent Breaches Key Level +18.97%
12:30PM  Why Eagle Pharmaceuticals, Inc. Is Soaring 21.6% Today at Motley Fool
09:33AM  CMS Establishes Unique J-Code for BENDEKA┬« (Bendamustine Hydrochloride) Injection Business Wire
Nov-01-16 04:05PM  Final Reminder: Eagle Pharmaceuticals to Host 2016 Investor Day in New York City Business Wire
Oct-31-16 07:00AM  Eagle Pharmaceuticals Announces Positive Initial Results of Animal Study Exploring Use of Ryanodex in MDMA (Ecstasy) Induced Hyperthermia Conducted at the National Institutes of Health Business Wire -8.12%
Oct-26-16 04:30PM  Eagle Pharmaceuticals, Inc. to Discuss Third Quarter 2016 Financial Results on November 9, 2016 Business Wire
Oct-19-16 08:20AM  Eagle Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : EGRX-US : October 19, 2016
Oct-12-16 09:46AM  ETFs with exposure to Eagle Pharmaceuticals, Inc. : October 12, 2016
Sep-27-16 04:30PM  Eagle Pharmaceuticals Announces Save the Date for 2016 Investor Day Business Wire +5.35%
Sep-20-16 10:18AM  ETFs with exposure to Eagle Pharmaceuticals, Inc. : September 20, 2016 +6.63%
Sep-13-16 08:09AM  EAGLE PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Sep-09-16 10:03AM  Why Eagle Pharmaceuticals Inc. Flew 38.5% Higher in August at Motley Fool
Sep-07-16 10:38AM  ETFs with exposure to Eagle Pharmaceuticals, Inc. : September 7, 2016
Aug-22-16 05:51PM  Chemical Financial Set to Join S&P MidCap 400; Supervalu, Shoe Carnival and Eagle Pharmaceuticals to Join S&P SmallCap 600 PR Newswire
Aug-15-16 10:21AM  ETFs with exposure to Eagle Pharmaceuticals, Inc. : August 15, 2016
Aug-12-16 10:53AM  Eagle Pharmaceuticals, Inc. :EGRX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016
Aug-10-16 08:00AM  Eagle Pharmaceuticals (EGRX) Soars: Stock Moves 14.6% Higher
07:08AM  EAGLE PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Aug-09-16 01:04PM  Shark Bites: Join the Momentum Parade +14.62%
11:21AM  Edited Transcript of EGRX earnings conference call or presentation 9-Aug-16 12:30pm GMT
07:31AM  EAGLE PHARMACEUTICALS, INC. Files SEC form 8-K, Financial Statements and Exhibits
07:07AM  Q2 2016 Eagle Pharmaceuticals Inc Earnings Release - Before Market Open
07:01AM  Eagle Pharmaceuticals posts 2Q profit
06:50AM  Eagle Pharmaceuticals, Inc. Reports Second Quarter 2016 Results Business Wire
06:45AM  Eagle Pharmaceuticals Reports Positive Outcome From FDA Meeting For RYANODEX For Exertional Heat Stroke NDA Submission Business Wire
Aug-08-16 04:32PM  EAGLE PHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
11:55AM  These 5 Stocks Are Set to Soar on Bullish Earnings
10:21AM  Medical Product Stocks' Earnings on Aug 9: PEN, STE & More
Aug-01-16 07:00PM  SHAREHOLDER ALERT: Rosen Law Firm Reminds Eagle Pharmaceuticals, Inc. Investors of Important August 1 Deadline in Class Action - EGRX GlobeNewswire +7.95%
01:40PM  EGRX Investors: The Wagner Firm Announces The Filing Of A Securities Class Action On Behalf of Eagle Pharmaceuticals Inc. Investors Business Wire
12:47PM  Eagle Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : EGRX-US : August 1, 2016
Jul-29-16 11:58AM  3-DAY DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Eagle Pharmaceuticals Inc. and Reminds Investors with Losses to Contact the Firm Accesswire
09:27AM  UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Shareholders of Eagle Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 1, 2016 - EGRX PR Newswire
Eagle Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing injectable products primarily in the critical care and oncology areas in the United States. The company offers argatroban to treat heparin-induced thrombocytopenia; Ryanodex injectable suspension for the treatment of malignant hyperthermia; non-alcohol docetaxel injection, a chemotherapeutic agent for the treatment of breast, non-small cell lung, prostate, head, and neck cancers/gastric adenocarcinoma; and diclofenac-misoprostol. It develops EP-3101, a bendamustine ready to dilute (RTD) liquid; EP-3102, a bendamustine short infusion time RTD liquid for the treatment of chronic lymphocytic leukemia and indolent non-Hodgkin's lymphoma; and EP-4104, a dantrolene for the treatment of exertional heat stroke. The company also develops EP-5101 (pemetrexed) as RTD liquid, which is in pre-clinical formulation and toxicology studies to treat lung cancer and mesothelioma; and EP-6101, a bivalirudin RTU liquid formulation for the treatment of percutaneous transluminal angioplasty. Eagle Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Woodcliff Lake, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Krill Steven L.EVP & Chief Scientific OfficerMar 23Option Exercise12.647,02588,8077,025Mar 24 04:41 PM
ProQuest Investments IV, L.P.10% OwnerMar 23Sale83.0170058,1073,778,087Mar 23 05:02 PM
Krill Steven L.EVP & Chief Scientific OfficerMar 23Sale82.067,025576,4890Mar 24 04:41 PM
Krill Steven L.EVP & Chief Scientific OfficerMar 22Option Exercise6.837,10048,5177,100Mar 24 04:41 PM
Edlin Richard A.DirectorMar 22Buy79.446,000476,64029,400Mar 22 04:47 PM
Krill Steven L.EVP & Chief Scientific OfficerMar 22Sale80.097,100568,6410Mar 24 04:41 PM
Pernock DavidPres. & Chief Comm. OfficerMar 21Buy83.98615,123511Mar 21 04:37 PM
ProQuest Investments IV, L.P.10% OwnerMar 21Sale83.1050041,5503,778,787Mar 23 05:02 PM
ProQuest Investments IV, L.P.10% OwnerMar 20Sale82.1051,8834,259,5943,779,287Mar 20 05:40 PM
ProQuest Investments IV, L.P.10% OwnerMar 17Sale82.0138,9973,198,1443,831,170Mar 20 05:40 PM
ProQuest Investments IV, L.P.10% OwnerMar 16Sale82.089,120748,5703,870,167Mar 20 05:40 PM
Pernock DavidPres. & Chief Comm. OfficerMar 09Buy77.8445035,028450Mar 10 07:20 PM
ProQuest Investments IV, L.P.10% OwnerJan 04Sale85.1665,1145,545,1083,879,287Jan 06 04:39 PM
Krill Steven L.EVP & Chief Scientific OfficerDec 23Option Exercise46.095,127236,3035,127Jan 04 07:19 PM
Krill Steven L.EVP & Chief Scientific OfficerDec 23Sale78.615,127403,0180Jan 04 07:19 PM
Krill Steven L.EVP & Chief Scientific OfficerDec 22Option Exercise46.095,126236,2575,126Jan 04 07:19 PM
Krill Steven L.EVP & Chief Scientific OfficerDec 22Sale76.785,126393,5710Jan 04 07:19 PM
Krill Steven L.EVP & Chief Scientific OfficerDec 21Option Exercise37.3310,252382,7427,569Jan 04 07:19 PM
Krill Steven L.EVP & Chief Scientific OfficerDec 21Sale77.1710,252791,1950Jan 04 07:19 PM
Krill Steven L.EVP & Chief Scientific OfficerDec 20Option Exercise12.6310,000126,30010,000Jan 04 07:19 PM
Krill Steven L.EVP & Chief Scientific OfficerDec 20Sale76.6910,000766,8760Jan 04 07:19 PM
Krill Steven L.EVP & Chief Scientific OfficerDec 19Option Exercise12.6410,000126,4077,317Jan 04 07:19 PM
Krill Steven L.EVP & Chief Scientific OfficerDec 19Sale75.6110,000756,0660Jan 04 07:19 PM
Krill Steven L.EVP & Chief Scientific OfficerDec 15Option Exercise9.5910,00095,9286,270Jan 04 07:19 PM
Krill Steven L.EVP & Chief Scientific OfficerDec 15Sale74.7910,000747,8960Jan 04 07:19 PM
Krill Steven L.EVP & Chief Scientific OfficerDec 13Option Exercise4.4210,00044,20010,000Dec 15 04:57 PM
Krill Steven L.EVP & Chief Scientific OfficerDec 13Sale73.6210,000736,1630Dec 15 04:57 PM
RATOFF STEVEN BDirectorDec 13Sale75.008,700652,50013,324Dec 14 04:29 PM
RATOFF STEVEN BDirectorDec 12Sale75.071,30097,59122,024Dec 14 04:29 PM
Krill Steven L.EVP & Chief Scientific OfficerNov 30Option Exercise7.805,78745,1112,530Dec 02 08:56 PM
Krill Steven L.EVP & Chief Scientific OfficerNov 30Sale80.005,787462,9600Dec 02 08:56 PM
FLAUM SANDER ADirectorNov 28Sale78.665,000393,30011,374Nov 30 05:12 PM
Krill Steven L.EVP & Chief Scientific OfficerNov 23Option Exercise8.782001,756200Dec 02 08:56 PM
Krill Steven L.EVP & Chief Scientific OfficerNov 23Sale80.0020016,0000Dec 02 08:56 PM
ProQuest Investments IV, L.P.10% OwnerNov 11Sale85.0015,5511,321,8353,944,401Nov 14 05:40 PM
ProQuest Investments IV, L.P.10% OwnerNov 10Sale85.2818,9351,614,7707,677Nov 14 05:40 PM
ProQuest Investments IV, L.P.10% OwnerNov 09Sale79.42148,80011,818,0653,977,287Nov 09 05:52 PM
ProQuest Investments IV, L.P.10% OwnerNov 07Sale75.395,030379,2124,126,087Nov 09 05:52 PM
ProQuest Investments IV, L.P.10% OwnerNov 04Sale75.0046,1703,462,7504,181,446Nov 04 05:07 PM
ProQuest Investments IV, L.P.10% OwnerNov 02Sale70.10199,60013,992,6357,977Nov 04 05:07 PM
ProQuest Investments IV, L.P.10% OwnerSep 30Sale70.0622,1001,548,3264,373,987Oct 04 04:20 PM
ProQuest Investments IV, L.P.10% OwnerSep 29Sale70.0477,9005,456,1164,396,087Sep 30 04:15 PM
ProQuest Investments IV, L.P.10% OwnerSep 21Sale66.1799,7956,603,4168,777Sep 23 05:15 PM
ProQuest Investments IV, L.P.10% OwnerSep 08Sale62.3334,0862,124,5808,971Sep 08 05:01 PM
ProQuest Investments IV, L.P.10% OwnerSep 07Sale62.2611,442712,3799,037Sep 08 05:01 PM
ProQuest Investments IV, L.P.10% OwnerSep 06Sale62.8425,3971,595,9049,059Sep 08 05:01 PM
ProQuest Investments IV, L.P.10% OwnerAug 24Sale62.7811,605728,5629,108Aug 25 04:10 PM
ProQuest Investments IV, L.P.10% OwnerAug 23Sale63.1417,2651,090,1099,131Aug 25 04:10 PM
ProQuest Investments IV, L.P.10% OwnerAug 17Sale61.0814,696897,6195,387Aug 17 06:00 PM
ProQuest Investments IV, L.P.10% OwnerAug 16Sale61.6760,1503,709,3915,416Aug 17 06:00 PM
ProQuest Investments IV, L.P.10% OwnerAug 15Sale60.7724,9491,516,1605,533Aug 17 06:00 PM
ProQuest Management LLC10% OwnerMay 13Sale40.9213,980572,06241,081May 16 04:41 PM
ProQuest Management LLC10% OwnerMay 12Sale40.004,000160,00055,061May 16 04:41 PM
Tarriff ScottPresident and CEOApr 01Sale40.6330,7651,249,9821,369,946Apr 05 05:06 PM